World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
85
Citations
32626
World Ranking
1304
National Ranking
15

Medicine

D-Index
87
Citations
33122
World Ranking
13515
National Ranking
68

Markus Reindl publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Markus Reindl sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 349 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Markus Reindl D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Markus Reindl sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 85 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Markus Reindl is affiliated with Innsbruck Medical University in Austria. Their research focus lies primarily within the field of medicine, with significant specialization in neurology and related subfields.

Their body of work spans several major subfields, including:

  • Neurology
  • Pathology and Forensic Medicine
  • Rheumatology
  • Infectious Diseases
  • Immunology

Reindl's publications extensively cover topics such as multiple sclerosis research, peripheral neuropathies, autoimmune neurological disorders, and neuroinflammation mechanisms. Key research topics include:

  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Systemic Lupus Erythematosus Research
  • Autoimmune Neurological Disorders and Treatments
  • SARS-CoV-2 and COVID-19 Research
  • Neuroinflammation and Neurodegeneration Mechanisms
  • COVID-19 Clinical Research Studies

Reindl has published notably in several academic journals, frequently contributing to:

  • Neurology Neuroimmunology & Neuroinflammation
  • European Journal of Paediatric Neurology
  • Neurology
  • Frontiers in Immunology
  • Multiple Sclerosis and Related Disorders

The recent publications involving Reindl include:

  • International multicenter examination of MOG antibody assays, 2020, Neurology Neuroimmunology & Neuroinflammation

Other notable papers coauthored by Reindl and colleagues which provide context to their research field are:

  • Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria, 2023, The Lancet Neurology
  • Myelin-oligodendrocyte glycoprotein antibody-associated disease, 2021, The Lancet Neurology
  • Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients, 2020, Multiple Sclerosis and Related Disorders
  • Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients, 2020, Journal of Neuroinflammation

Frequent collaborators in Reindl's publications include:

  • Kevin Rostásy
  • Kathrin Schanda
  • Eva-Maria Wendel
  • Matthias Baumann
  • Christian Lechner

Best Publications

  • A clinical approach to diagnosis of autoimmune encephalitis

    Francesc Graus;Maarten J. Titulaer;Ramani Balu;Susanne Benseler

  • Toll-like Receptor 4 Polymorphisms and Atherogenesis

    Stefan Kiechl;Eva Lorenz;Markus Reindl;Christian J Wiedermann

  • Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria

    Unknown

  • MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

    Sven Jarius;Klemens Ruprecht;Ingo Kleiter;Nadja Borisow

  • Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event

    Thomas Berger;Paul Rubner;Franz Schautzer;Robert Egg

  • Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia

    Lisa Fellner;Regina Irschick;Kathrin Schanda;Markus Reindl

  • Myelin oligodendrocyte glycoprotein antibodies in neurological disease.

    Markus Reindl;Patrick Waters

  • Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

    Monika Bradl;Tatsuro Misu;Toshiyuki Takahashi;Mitsutoshi Watanabe

  • Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.

    Simone Mader;Viktoria Gredler;Kathrin Schanda;Kevin Rostasy

  • Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

    Maarten J. Titulaer;Maarten J. Titulaer;Romana Höftberger;Romana Höftberger;Takahiro Iizuka;Frank Leypoldt;Frank Leypoldt

  • MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.

    Sven Jarius;Klemens Ruprecht;Ingo Kleiter;Nadja Borisow

  • Antibody to aquaporin-4 in the Long-Term Course of Neuromyelitis Optica

    S Jarius;F Aboul-Enein;P Waters;B Kuenz

  • Myelin-oligodendrocyte glycoprotein antibody-associated disease.

    Romain Marignier;Romain Marignier;Yael Hacohen;Alvaro Cobo-Calvo;Anne Katrin Pröbstel

  • The spectrum of MOG autoantibody-associated demyelinating diseases

    Markus Reindl;Franziska Di Pauli;Kevin Rostásy;Thomas Berger

  • Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.

    Markus Reindl;Chris Linington;Uschi Brehm;Robert Egg

  • MOG cell-based assay detects non-MS patients with inflammatory neurologic disease

    P Waters;M Woodhall;K C O'Connor;M Reindl

  • Axl and growth arrest - Specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme

    Markus Hutterer;Pjotr Knyazev;Ariane Abate;Markus Reschke

  • Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein

    M. Baumann;K. Sahin;C. Lechner;E. M. Hennes;E. M. Hennes

  • Cellular Aging Reflected by Leukocyte Telomere Length Predicts Advanced Atherosclerosis and Cardiovascular Disease Risk

    Peter Willeit;Johann Willeit;Anita Brandstätter;Silvia Ehrlenbach

  • Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome

    Eva-Maria Hennes;Matthias Baumann;Kathrin Schanda;Banu Anlar

  • Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease

    Romana Höftberger;María Sepulveda;Thaís Armangue;Yolanda Blanco

Frequent Co-Authors

Friedemann Paul
Friedemann Paul Charité - University Medicine Berlin
Werner Poewe
Werner Poewe Innsbruck Medical University
Hans Lassmann
Hans Lassmann Medical University of Vienna
Brigitte Wildemann
Brigitte Wildemann University Hospital Heidelberg
Patrick Waters
Patrick Waters University of Oxford
Gregor K. Wenning
Gregor K. Wenning Innsbruck Medical University
Kazuo Fujihara
Kazuo Fujihara Fukushima Medical University
Klemens Ruprecht
Klemens Ruprecht Charité - University Medicine Berlin
Peter G. Kremsner
Peter G. Kremsner University of Tübingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related degrees in nursing and healthcare can open diverse career opportunities. Many professionals start with foundational nursing qualifications, which can be attained through various online programs designed for non-traditional students.

If you are starting without prior nursing experience, exploring online adn programs for non nurses offers an accessible route into nursing practice. These programs focus on building essential clinical skills and knowledge necessary for advancing into specialized fields like Immunology.

For faster entry, consider accelerated bsn programs for non nurses, which are tailored for individuals seeking to expedite their Bachelor of Science in Nursing degree. These programs serve as a stepping stone toward roles that require more advanced expertise and certification.

Nursing assistants and licensed practical nurses play critical roles in healthcare teams. Identifying the best easiest lpn programs to get into can help you start your career swiftly and effectively.

For those aiming for higher clinical responsibility, exploring accelerated np programs online is advisable. These programs provide advanced training and enable practice as a Nurse Practitioner in various specialties, including Immunology-related care.

Best Scientists Citing Markus Reindl

Trending Scientists

Recently Published Articles